Table: Takara Bio -Q1 group results
Aug 8 (Reuters)-
Takara Bio Inc.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2024 Jun 30, 2023 Mar 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 8.49 9.18 48.90
(-7.4 pct) (-34.9 pct) (+12.4 pct)
Operating loss 1.63 423 mln 5.00
(-90.7 pct) (+66.5 pct)
Recurring loss 1.50 509 mln 5.20
(-88.9 pct) (+52.7 pct)
Net loss 1.05 319 mln 3.40
(-91.8 pct) (+129.6 pct)
EPS loss 8.70 yen 2.65 yen 28.24 yen
Ann Div 17.00 yen 17.00 yen
-Q2 div NIL NIL
-Q4 div 17.00 yen 17.00 yen
NOTE - Takara Bio Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T